Research & Testing Partners
Cynvenio offers a suite of proprietary, distributable LiquidBiopsy® platforms and consumables for deployment in hospitals and third party diagnostic labs. Visit www.cynvenio.com for more information about our platforms and consumables.
Testing and research partners can choose to deploy our platform in-house or to leverage Cynvenio’s CLIA/CAP lab to quickly gain traction in their home markets with minimal investment. Partner benefits include:
- Immediately integrate targeted comprehensive panels
- Training and ongoing support
- Discount on equipment purchase when enrolled in technology transfer program
Cynvenio’s LiquidBiopsy technology has patented in North America, China and Europe and validated through partnerships with major cancer centers such as UCLA’s Jonsson Comprehensive Cancer Center and USC’s Norris Cancer Center (Los Angeles, CA), Memorial Sloan-Kettering (New York, NY), and Jefferson University Kimmel Cancer Center (Philadelphia, PA).